Vivo Bio Tech Ltd files a mandatory SEBI compliance report on physical share transfer re-lodgements for April 2026.
The report, from RTA Aarthi Consultants, confirms zero requests received, processed, approved, or rejected during the period.
The filing is pursuant to SEBI Circular HO/38/13/11(2)2026-MIRSD-POD/I/3750/2026 dated January 30, 2026.